Clinical studies on chemokines and cytokines have yielded mixed results: during migraine attacks, levels of pro-inflammatory mediators such as interleukin-1β (IL-1β), IL-6, and IL-8 increase, while levels of anti-inflammatory mediators both increase (IL-10) and decrease (IL-4 and IL-5) [26]. This evidence concerns the gene IL1B and migraine disorder.